BioSpace News Archive

Mediclinic Middle East, located in Dubai, Al Ain, and Abu Dhabi in the United Arab Emirates (UAE), has joined the TriNetX network to help grow the hospital group’s overall research portfolio and expand its clinical trial opportunities.

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will present at the Jefferies 2020 Virtual London Healthcare Conference. Mark Iwicki, Chairman and Chief Executive Officer of Kala Pharmaceuticals, is scheduled to participate in a fireside chat on Tuesday, November 17,

University of Pennsylvania Medical Center, has enrolled their first patient in the VESAIR Clinical Trial. The Vesair Clinical Study is being conducted in several distinguished clinics throughout the US to test the safety and efficacy of the Vesair Bladder Control Balloon procedure.

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its Senior Vice President of Intellectual Property and Licensing, Thomas Gallagher, will participate in a panel discussion titled, “Show Me the Money: Preparing Your Company for Funding,” at the annual NYC-based Life Sciences Summit,

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the Stifel Virtual Healthcare Conference on November 17 and participate in the A.G.P. Virtual Healthcare Symposium on November 19.

Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it will be presenting at the Virtual Fall Investor Summit to be held virtually on November 16-18, 2020. Leonard Osser, Interim Chief Executive Officer, is scheduled to present on Wednesday, November 18 th at 9:30 a.m., Eastern Time.

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, today announced a research collaboration with NRGene® that includes the adoption of NRGene’s cloud-based genomics platform to support key Calyxt’s research projects.

Cerner Corporation, a global health care technology company, announced new capabilities designed to take interaction between clinicians and patients beyond email to text message conversations, helping solve for a gap in communication in health care.

Tridiuum, the nation’s premier provider of digital behavioral health solutions, today announced that Philip Vecchiolli has joined the company as Chief Growth and Strategy Officer.

Chiesi USA (key-ay-zee), a specialty pharmaceutical company based in Cary, N.C., earned the Triangle Business Journal’s 2020 Corporate Philanthropy Award in the Large Company category for the fourth year running. The recognition honors the work of companies, nonprofits and outstanding citizens through philanthropy, volunteerism, board support and corporate partnerships in 2019. In 2019, Chiesi’s employee-led corporate social responsibility prog